111 Inc - ADR

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

111 Inc achieves operational profitability in Q1 2024 earnings call

111 Inc's Q1 2024 performance reflects a shift towards profitability, driven by operational efficiency and strategic initiatives. While facing challenges in expense optimization, the company is well-positioned to capitalize on market opportunities through listing options and expansion plans.

111 Inc reports operational profitability and strategic growth initiatives in Q2 2024

111 Inc's Q2 2024 earnings call showcased operational profitability, cost reductions, and strategic advancements in digital transformation and supply chain management. The company's focus on growth in the health care industry, expansion of patents, and plans for further logistics network development position it for continued success amidst challenges and evolving market trends.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Agriforce Growing Systems Ltd

Maison Solutions Inc

Webuy Global Ltd

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 4 Defensive Stocks That Could Lead To Your Biggest Gains This Quarter - AgriFORCE Growing Systems (NASDAQ:AGRI), Maison Solutions (NASDAQ:MSS)

111, Inc. (NASDAQ:YI ) Q3 2023 Results Conference Call November 30, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO of 111's Major Subsidiary Haihui Wang - COO Conference Call Participants Xipeng Feng - CIBC Tom Craig - Cornerstone Investment Ethan Ling - Iron Harbor Capital Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

111, Inc. (YI) Q3 2023 Earnings Call Transcript

SHANGHAI , Nov. 30, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights Net revenues were RMB3.7 billion (US$502.4 million), representing an increase of 9.5% year-over-year.

111, Inc. Announces Third Quarter 2023 Unaudited Financial Results

Albertsons Companies

iRobot

In the US business landscape, strategic mergers and acquisitions often set the stage for remarkable returns for shareholders. In the wake of economic shifts, three key M&A plays emerge as focal points, poised to redefine market dynamics and investor strategies.

3 Top M&A Plays: Lucrative Merger Deals Poised for Big Payoffs

SHANGHAI , Nov. 13, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2023, before the U.S. market opens on Thursday, November 30, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 30, 2023 (8:30 PM Beijing Time on the same day).

111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow

111, Inc. (NASDAQ:YI ) Q2 2023 Earnings Conference Call August 24, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman, and Chief Executive Officer Luke Chen - Chief Executive Officer, 111's Major Subsidiary Haihui Wang - Chief Operating Officer Conference Call Participants Xipeng Feng - CICC Jessie Lu - HSBC Steven Lin - Private Investor Ethan Ling - Iron Harbor Capital Operator Hello, everyone and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Dr. Junling Liu, Co-Founder, Chairman, and CEO; Dr. Luke Chen, CEO of 111's Major Subsidiary; and Dr. Haihui Wang, COO.

111, Inc. (YI) Q2 2023 Earnings Call Transcript

SHANGHAI , Aug. 24, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights Net revenues were RMB3.5 billion (US$479.6 million), representing an increase of 14.5% year-over-year.

111, Inc. Announces Second Quarter 2023 Unaudited Financial Results

SHANGHAI , July 31, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2023, before the U.S. market opens on Thursday, August 24, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, August 24, 2023 (7:30 PM Beijing Time on the same day).

111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow

The Covid lockdown headwinds could only temporarily dent the relentless progress the company is making, growing revenue, expanding gross margin, and producing substantial operating leverage. We can't think of any even half plausible reason why this relentless progress should not continue, at most marginally less vigorous. Yet the share price is lingering at rock-bottom valuations, despite even a take-out offer 50% above the current share price.

111, Inc. Turns Profitable

111, Inc. (NASDAQ:YI ) Q1 2023 Earnings Conference Call June 15, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Harvey Wang - Chief Operating Officer Conference Call Participants Xipeng Feng - CICC Kevin Wang - Private Investor Operator Hello, everyone and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

111, Inc. (YI) Q1 2023 Earnings Call Transcript

SHANGHAI , June 15, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights Net revenues were RMB3.7 billion (US$538.3 million), representing an increase of 23.9% year-over-year.

111, Inc. Announces First Quarter 2023 Unaudited Financial Results

SHANGHAI , May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens on Thursday, June 15, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, June 15, 2023 (7:30 PM Beijing Time on the same day).

111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow

111, Inc. (NASDAQ:YI ) Q4 2022 Earnings Conference Call March 23, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Harvey Wang - Chief Operating Officer Conference Call Participants Xipeng Feng - CICC Stephen Lee - Individual Investor Tom Craig - Cornerstone Investment Francis Yang - BSV Capital Operator Hello, everyone and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

111, Inc. (YI) Q4 2022 Earnings Call Transcript

SHANGHAI , March 23, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Highlights Net revenues were RMB4.1 billion (US$601.4 million), representing an increase of 19.9% year-over-year.

111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results

SHANGHAI , March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2022 ended December 31, 2022, before the U.S. market opens on Thursday, March 23, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 23, 2023 (7:30 PM Beijing Time on the same day).

111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow

SHANGHAI , Feb. 16, 2023 /PRNewswire/ -- On February 15, 2023, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced that during the HuaTangNing® Market Launch for Innovative Commerce Cooperation, Dr. Yu Gang, Co-founder and Executive Chairman of 111, and Dr. Chen Li, Founder and CEO of Hua Medicine (HKEx stock code: 2552.HK), jointly unveiled the plaque of Hua Medicine's first official online flagship store on 111. 111 is committed to digitally connecting patients with medicine and healthcare services, aspiring to build itself into an integrated online and offline healthcare platform.

111, Inc. Hosts Hua Medicine Launches First Official Flagship Store

111, Inc. has received a non-binding proposal to be acquired by a consortium led by the company's founders at $3.66/ADS. YI share price has recently soared, jumping to as much as 9% above the offer and seems to have settled slightly below the privatization price.

111, Inc.: Privatization With An Interesting Twist

111, Inc. (NASDAQ:YI ) Q3 2022 Earnings Conference Call December 1, 2022 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer, Major Subsidiary Harvey Wang - Chief Operating Officer Monica Mu - Investor Relations Director Conference Call Participants Zoe Bian - Citi Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

111, Inc. (YI) Q3 2022 Earnings Call Transcript

SHANGHAI , Dec. 1, 2022 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Key Results Net revenues were RMB3.35 billion (US$470.8 million), representing an increase of 0.1% year-over-year.

111, Inc. Announces Third Quarter 2022 Unaudited Financial Results

SHANGHAI , Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2022, before the U.S. market opens on Thursday, December 1, 2022. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, December 1, 2022 (8:30 PM Beijing Time on the same day).

111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow

SHANGHAI , Sept. 23, 2022 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), consisting of three independent directors, Mr.

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

SHANGHAI , Sept. 9, 2022 /PRNewswire/ -- 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding proposal letter (the "Proposal") dated September 9, 2022 jointly submitted by Dr. Gang Yu, co-founder and co-chairman of the Company, Mr.

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

111, Inc. (NASDAQ:YI ) Q2 2022 Earnings Conference Call August 25, 2022 7:30 AM ET Company Participants Monica Mu - Investor Relations Director Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer, Major Subsidiary Harvey Wangg - Chief Operating Officer Conference Call Participants Xipeng Feng - CICC Zoe Bian - Citi Operator Hello everyone and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

111, Inc. (YI) Q2 2022 Earnings Call Transcript

SHANGHAI , Aug. 25, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Key Results Net revenues were RMB3.04 billion (US$453.4 million), representing an increase of 0.4% year-over-year.

111, Inc. Announces Second Quarter 2022 Unaudited Financial Results

SHANGHAI , Aug. 5, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2022, before the U.S. market opens on Thursday, August 25, 2022. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, August 25, 2022 (7:30 PM Beijing Time on the same day).

News for 111 Inc - ADR Stock (YI)